The Leydig cell-specific factor insulin-like peptide 3 (INSL3) is involved in testicular descent during embryo development, and has been suggested to regulate spermatogenesis and bone metabolism in the adult. Using a new, sensitive assay specific for rodent INSL3, we have mapped the secretion of INSL3 into peripheral blood in mice and during postnatal male rat development (in female rats, circulating INSL3 is at the level of detection). Maximum INSL3 is measured at Postnatal Day (PD) 40 in the rat and decreases to a significantly lower, stable value by PD60, indicating an ''overshoot'' effect in the establishment of Leydig cell functionality during the first wave of spermatogenesis. Aging rats (;24 mo) have markedly reduced circulating INSL3 levels, as do humans. Treatment of young adult rats with ethane dimethylsulfonate (EDS) leads to loss of mature Leydig cells and no detectable INSL3 in peripheral blood. INSL3 can be detected first at Day 27 after EDS treatment, returning to near normal levels by Day 37. Both primary rat Leydig cells and the mouse MA-10 tumor cell line secrete substantial amounts of INSL3 into the culture media in a constitutive manner, unregulated by common effectors, including hCG. Analysis of different testicular fluid compartments shows highest INSL3 concentration in the interstitial fluid (391.4 6 47.8 ng/ml). However, INSL3 evidently traverses the bloodtestis barrier to enter the seminiferous compartment, rete testis, and epididymis in sufficient concentration to be able to address the specific INSL3 receptors (RXFP2) on post-meiotic germ cells and in the epididymis.
INTRODUCTION
The peptide hormone, insulin-like peptide 3 (INSL3; formerly, relaxin-like factor), is related evolutionarily to relaxin and to the neuropeptide relaxin-3 [1] . In the male, INSL3 is a major product of the testicular Leydig cells, where its mRNA appears to be constitutively expressed in a differentiationdependent manner correlating with the postnatal development of Leydig cell function [2, 3] . The Insl3 gene is also expressed in fetal Leydig cells, where studies with knockout mice have identified a role in promoting the first transabdominal phase of testicular descent [4, 5] . In the adult testis, its function is less well characterized, with available evidence suggesting an antiapoptotic or survival factor role in regard to germ cells [6, 7] . A recent study in the human supports this: subjects who had responded less markedly to a steroidal contraceptive regimen with higher residual sperm counts had significantly increased circulating levels of INSL3, implying a protective effect of this hormone [8] .
INSL3 is the specific ligand of the RXFP2 (formerly, LGR8 or Great) receptor. This is a Class C G proteincoupled receptor, which, at least in cells transfected with recombinant receptor, appears to signal in a Gs-dependent fashion to generate cAMP [9, 10] . In the fetus, RXFP2 mRNA is highly expressed on the gubernacular ligament, in agreement with its function in promoting testicular descent [11] . It is also expressed on the cremaster muscle and on parts of the Wolffian duct [12, 13] . In the adult, RXFP2 is expressed at both protein and gene levels on postmitotic male germ cells, as well as on Leydig cells and in the epididymis [7, 12, 13] .
Recently, immunoassays have been developed that are able to measure INSL3 in human body fluids [14] [15] [16] , and there is one preliminary study addressing expression in the rat [17] . These studies confirm that INSL3 is a major product of the testicular Leydig cells, with circulating concentrations reflecting their number and/or differentiation status [16, 18] . Recent studies in the human suggest that INSL3 could become a very important parameter for measuring the true functionality of the Leydig cells and hence their steroidogenic capacity, independently of other influences on the HPG axis [16, 18, 19] . In humans, circulating INSL3 increases through puberty, to reach a maximum in early adulthood, and subsequently appears to decline to significantly lower plasma levels in aging men [16, 20] . In regard to the fetal population of Leydig cells, maximal levels of INSL3 peptide were detected in human amniotic fluid collected from women at the beginning of the second trimester, a time when the first phase of testicular descent is ongoing or just completed, and then only when carrying a male, but not a female fetus [21] .
The present study examines whether, for rodents, the results obtained for INSL3 at the mRNA level were representative of events at the hormonal level, and, thus, could also serve as reliable models for the human. Secondly, although INSL3 is produced uniquely by the Leydig cells within the interstitial compartment [2, 22, 23] , all available evidence points to a function for INSL3 at receptors on postmeiotic germ cells within the seminiferous tubules and, possibly, the epididymis [7, 12, 13] . This is a compartment that is segregated from the interstitial compartment and from blood vessels by a relatively impermeable and/or selective tight junction barrier between Sertoli cells [24] [25] [26] [27] , which themselves do not express RXFP2 receptors [7, 12, 13] . The question, therefore, needs to be addressed as to whether and how Leydig cell INSL3 is able to reach the tubular compartment to carry out possible functions there.
MATERIALS AND METHODS

Immunoassays
Heterodimeric rat INSL3 was synthesized by Dr. John Wade at the Howard Florey Institute, Melbourne, Australia. The peptide was shown by HPLC and mass spectrometry (MS) to be .99% pure, and conformed to the expected molecular structure. Polyclonal antibodies were raised in New Zealand white rabbits, as previously described [15, 28] . The serum indicating the highest titer against the immunizing antigen was then used to develop a specific immunoassay on a time-resolved fluorescence immunoassay (TRFIA) platform. Europium-labeled tracer was produced exactly as described for human INSL3 [15, 16] , except using the pure rat peptide. The TRFIA assay was designed essentially as previously described [15, 29] , except that microtiter fluoroNunc strips (Nunc, Roskilde, Denmark) were coated with 1 lg/well affinity-purified goat anti-rabbit IgG (Rockland, Gilbertsville, PA) with long-term storage at À208C. A sample volume of 50 ll was used throughout. Standards represented concentrations of 20 pg to 5 ng rat INSL3 per ml, and covered the full range of measurement. Rabbit anti-rat INSL3 antiserum was applied without further purification at a final dilution of 1 in 5000. After addition of samples or standards and antibody, plates were incubated for 20 h in a dark, humid chamber, with gentle shaking at 48C. Plates were then washed once, and tracer added (500 000 cps/well) with further incubation for 2 h in the dark at 48C without shaking. Plates were then washed four times before addition of 200 ll of enhancement solution and further incubation at 48C. Plates were read after 60 min in a Victor 3 1420 multilabel counter (Perkin Elmer, Boston, MA), by pulsing samples with 1000/sec excitation light of 340-nm band detecting emitted light at 615 nm, with a delay of 400 lsec after each flash to minimize nonspecific background fluorescence.
In order to detect human INSL3 after injection into male rats, a new human INSL3 TRFIA was developed, since the previous assay [15, 16] had made use of specific rat anti-human INSL3 antisera, and could thus potentially cross-react with rat sera. Anti-human INSL3 polyclonal antibody (G-035-27) raised in rabbits was a generous gift from Dr. Jun Yang (Phoenix Pharmaceuticals Inc., Burlingame, CA). After preliminary experiments, this antibody was substituted into our previously described [16] human INSL3 TRFIA at a final dilution of 1:4000. As tracer, we used the same Europium-labeled human INSL3 as previously described [16] . All other conditions were also similar. We found no crossreactivity in this assay with relaxin, IGF1, IGF2, or insulin, and, most importantly, no crossreactivity towards rat INSL3 up to a concentration of 50 ng/ml, nor with any components of undiluted male or female rat sera. The operating limits of this assay were from 20 pg/ml to 3.2ng/ml human INSL3, with inter-and intra-assay coefficients of variation in the midrange of 7% and 3%, respectively.
Animal Experiments
All animal experiments were authorized by the local university ethics committee. Sprague-Dawley (SD) or Wistar rats of different ages (as indicated), either from the Laboratory Animal Services colony at the University of Adelaide, or from the Australian Resource Centre, Perth, Australia, were killed under CO 2 anesthesia, blood collected from the posterior vena cava, and sera or plasma stored frozen at À208C until analysis. Similarly, sera were collected also from male and female CBA mice, as indicated.
Postnatal time course of peripheral INSL3 concentration. In order to obtain blood from rats of precise age postnatally through puberty, pregnant SD rats were followed, and the exact date of delivery determined. Male pups were weaned on Day 21 and thereafter fed ad libitum with standard chow. At the days indicated, rats were killed between 1400 and 1500 h, and trunk blood and other tissues collected.
Peripheral INSL3 profile following Leydig cell ablation. In a second set of experiments, adult SD rats of ;90 days of age were given a single bolus i.p. injection (Day 1) of ethane dimethylsulfonate (EDS; 75 mg/kg body weight; a generous gift from Dr. Katja Teerds, Groningen, Netherlands) to eliminate adult Leydig cells [30] . Animals were killed at 0 (control), 10, 14, 19, 27, and 37 days, blood samples collected, and plasma stored as described above.
Distribution of INSL3 in different testicular compartment. In order to study the distribution of INSL3 in different compartments of the male reproductive system, male Wistar rats (3-6 mo old; ;350 g) were used. Rats were anesthetized with pentobarbitone sodium (60 mg/kg, i.p.), the testes were exteriorized through the scrotal skin, and testicular venous plasma (TVP) collected in heparinized microhematocrit tubes from the veins near the caput epididymidis [31] . The microhematocrit tubes were emptied into Eppendorf tubes on ice. The testes were then removed and interstitial extracellular fluid (IEF) collected as follows: a silk suture was tied through the dorsal pole, and four small incisions were made through the tunica albuginea on the opposite pole; the testis was then suspended by the suture within the barrel of a 10-ml syringe with a 0.5-ml Eppendorf tube attached to the nozzle. This was centrifuged at 60 3 g for 45 min at 48C, as described by others [32] [33] [34] [35] . The volume of fluid collected was ;70 ll, which is slightly less than the estimate (;90 ll) derived from using the extracellular fluid marker, Cr-EDTA [36, 37] . The testis was then decapsulated and the parenchyma rinsed three times in 5-ml PBS and then forced through a 21-gauge needle with a 5-ml syringe into an Eppendorf tube. This cell dispersion was centrifuged at 13 400 3 g for 20 min at 48C, and the supernatant fluid separated as previously described [32, 33, 38] . This supernatant was comprised mostly of fluid from within the lumen of the seminiferous tubules (STF). However, the final wash still contained substantial amounts of INSL3 (data not shown), such that a substantial part of the STF value might be due to contaminating IEF. Diluted epididymal fluid (EpiF) was obtained as supernatant by macerating the cleanly dissected cauda epididymidis with fine scissors in a 35 3 10-mm Petri dish (BD Falcon easy grip; BD, Franklin Lakes, NJ) containing 500 ll PBS. Some fluid was drawn into a microhematocrit tube for determination of the diluted spermatocrit and the remainder centrifuged at 13 400 3 g (20 min, 48C). Assuming that the original spermatocrit of the epididymal luminal content was 50% [39] , the degree of dilution of the epididymal fluid, and hence the original EpiF concentration of INSL3, could be calculated from the spermatocrit of the diluted fluid using the formula: concentration of INSL3 measured 3 50 3 total length of the fluid in the hematocrit tube/100 3 length of cells occupying the hematocrit tube. The second set of animals was subjected to unilateral efferent duct ligation [40] by exteriorizing the testes through an incision in the lower abdomen. The animals were allowed to recover, and were anesthetized again 16 h later, when rete testis fluid (RTF) was collected into a nonheparinized microhematocrit tube after puncturing the distended rete, as previously described [41] . TVP was collected as above from the unligated testis. Results from the previous set of experiments suggest that the STF is likely to be significantly contaminated with interstitial fluid, so that measurement of INSL3 content inside the seminiferous tubule compartment using that method of estimation is of dubious value. As alternative estimate, the ''additional testicular fluid'' (ATF) concentration, was calculated by comparing the total testicular fluid (IEF þ STF) between ligated and unligated testes of the same animal [42] . Briefly, following the collection of RTF from the ligated testis and TVP from the unligated testis, the testes were decapsulated, parenchyma dispersed, and STF collected as described above. The efferent duct-ligated testes had 277 6 57.8 ll (n ¼ 5) more fluid than the unligated ones. It is known [36, 37] that the volume of IEF, as estimated from the volume of distribution of Cr-EDTA, does not change appreciably 16 h after efferent duct ligation. Furthermore, the volume of the interstitial tissue, estimated morphometrically on frozen sections, is no different 16 h after efferent duct ligation, and testicular blood flow is also unaffected [36, 37] . This confirms that the increased volume of supernatant from the ligated testes is due to fluid accumulation in the seminiferous tubule compartment. The concentration of INSL3 in this ATF can then be calculated using the formula: (conc. LTF 3 vol. LTF) À (conc. UTF 3 vol. UTF)/(vol. LTF À vol. UTF), where LTF and UTF are the ligated and unligated testicular fluids, respectively [42] . EpiF was collected as described above. Trunk blood was collected from all animals into heparinized tubes, kept on ice, and peripheral blood plasma (PBP) was prepared after 1 h by centrifuging at 1680 3 g (20 min, 48C). All fluids collected were stored at À208C.
Intratesticular injection of human INSL3. Adult Wistar rats were anesthetized as described above. In a preliminary experiment, for four animals, each testis received an injection of 100 ng human INSL3 in 20 ll PBS containing 1.2% bovine serum albumin (Calbiochem, Kilsyth, Australia) directly into the interstitial space with a Hamilton syringe. TVP and IEF were collected from the eight individual testes after 30 min or 1, 2, or 4 h (two testes from separate rats per time point), and stored at À208C. Additionally, two further testes from a fifth animal were sampled as described above at 30 min each. Human INSL3 was then measured in the fluids collected using a modified TRFIA specific for human INSL3 (see above). For a second group of rats, the efferent ducts were ligated bilaterally; 16 h later, each testis received an injection of 100 ng human INSL3 into the interstitial space, as in the previous set. Exactly 30 min later, TVP, IEF, RTF, and PBP were collected and processed for the specific measurement of human INSL3. Appropriate controls were run for both sets where the testes were injected with vehicle.
Cell Culture
The MA-10 mouse tumor Leydig cell line was cultured as previously described [3] . Initial experiments looked at the accumulation over time of INSL3 in culture media in unstimulated cells. Subsequent cultures were stimulated or not, as indicated, with 5 ng/ml hCG (Sigma, Castle Hill, NSW, Australia), 1 mM 8Br-cAMP (Biolog, Bremen, Germany), testosterone (Sigma), and/or monobutyl phthalate (MBP; TCI, Tokyo, Japan). Messenger RNA was measured using quantitative RT-PCR (qRT-PCR), as previously described [7] , with mouse Insl3-and Rps27a-specific primers [3] . Experiments
INSL3 DYNAMICS IN THE RAT TESTIS
were also carried out with primary cultures of Leydig cells prepared from adult (90-day-old) Wistar rats, as previously described [43] .
Statistics
All experiments were completely repeated at least once. Significant differences (minimum P , 0.05) were determined either by two-tailed ANOVA followed by a post hoc Newman-Keuls test, or by t statistics.
RESULTS
Establishment of a Sensitive TRFIA Measuring Rodent INSL3 in Peripheral Sera and Other Body Fluids
A sensitive sandwich TRFIA was developed, similar to the one we had produced to measure human INSL3 [15, 16] . The new assay uses a rabbit polyclonal antiserum raised against the mature A-B heterodimeric rat INSL3 in its native conformation. As tracer, rat heterodimeric INSL3 was labeled with Europium chelate. The upper and lower limits of detection of the new assay are 5.0 and 0.02 ng/ml for sera, plasma, or cell culture media, with within-plate coefficients of variation in the upper, middle, and lower detection range of 5.10%, 0.22%, and 11.21%, respectively. Between-plate coefficient of variation was 2.8% in the midrange. There was no detectable crossreactivity in this assay with porcine relaxin, human recombinant relaxin, human IGF1, human IGF2, human insulin, or human INSL3 and bovine/sheep INSL3, although this assay appears to detect mouse INSL3 as effectively as rat INSL3. Table 1 summarizes key data, also emphasizing its specificity, in that female rats and mice show levels of INSL3 in peripheral serum only at the lower detection limits. We observed no significant differences in the concentration of INSL3 measured in repeat samples of serum or plasma from the same animal. In addition, repeated freeze-thaw cycles (up to four cycles tested) had no significant effect on sample measurement.
Peripheral Concentrations of INSL3 During Postnatal Rat Development
For SD rats, INSL3 is first detectable in peripheral serum (trunk blood) at Day 20 and increases to a maximum of 4-10 ng/ml by Day 40 (Fig. 1) . Importantly, this maximum is substantially higher than the final established value in adulthood at 3 mo. Before Day 20, there appears to be no circulating INSL3, even though there are still remnants of the fetal Leydig cell population [43] . Samples collected in aged rats (.23 mo) are markedly lower in levels of INSL3, irrespective of strain (Table 1) , and confirm previous reports of an agedependent loss in testicular INSL3 immunoreactivity as well as mRNA expression [44] . It should be noted that female rodents consistently have very low peripheral INSL3 concentrations, although generally above the detection limits of the assay. 
Circulating Concentration of INSL3 Following EDS Treatment of Adult Male Rats
The alkylating agent, EDS, specifically destroys the differentiated population of adult-type Leydig cells [30] . In the absence of supplementary androgens, there is a compensatory increase in LH, which promotes the differentiation of new Leydig cells from peritubular stem cells [30] . Here (Fig. 2) , we show first that EDS treatment effectively reduced circulating INSL3 levels by Day 10 to below the level of detection for the TRFIA assay. Significant levels of INSL3 were again detectable in the circulation at Day 27 after EDS treatment, increasing to almost normal levels by Day 37.
Expression of INSL3 Peptide by Leydig Cells in Culture
Many studies have looked at Insl3 gene expression by assessing the specific mRNA inside cells. It is assumed that this represents a useful physiological parameter. However, this is only true if it can be shown that mRNA is translated and that the protein product is secreted in a biologically appropriate form and in an amount that corresponds to the mRNA measured. Because the TRFIA is designed to recognize heterodimeric INSL3 in native conformation, we tested whether Leydig cells in culture indeed secrete potentially functional INSL3 into the medium, and whether this can be regulated. We show here, for the first time (Fig.  3) , that INSL3 is indeed secreted by both MA-10 mouse tumor Leydig cells and by primary adult rat Leydig cells in culture. In both systems, various concentrations of common Leydig cell effectors, such as hCG, atrionatriuretic peptide, or phorbol myristate acetate (e.g., Fig. 3 , B and C), had no influence on secretion levels, confirming previous mRNA studies [2, 3] indicating that INSL3 is a constitutive product of the Leydig cell, and is not acutely regulated. Recently, it has been suggested [45] that androgens and phthalates at high concentration may modulate Insl3 gene expression in cultured Leydig cells. However, we failed to detect any change with testosterone or MBP at several concentrations, either at the level of mRNA expression (Fig. 4, inset) , or at the level of INSL3 peptide secretion at both 8 and 32 h (Fig.  4) .
Intratesticular Transport of INSL3 Within the Testis
Several studies highlight a role for INSL3 in the adult testis in relation to spermatogenesis, specifically as a survival or antiapoptotic factor. Indeed, specific receptors are expressed at protein and mRNA levels, particularly on postmeiotic germ cells, as well as in the epididymis [7, 12, 13] . However, the only cell type proven to produce INSL3 in the testis is the interstitial Leydig cell, which is separated from the seminiferous compartment by a well-established barrier of Sertoli cell tight junctions, besides the physical barrier of the tubule basal wall and peritubular myoid cells [24] [25] [26] [27] . To verify the plausibility of INSL3 functioning as a postmeiotic germ cell survival factor, we analyzed fluids collected from discrete testicular compartments for the presence of the peptide (Table  2) . INSL3 was very highly concentrated in IEF, and is also present in testicular venous plasma (TVP), the latter being 
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some 5-to 6-fold more highly concentrated than in trunk blood (PBP). Importantly, there were notable concentrations in accumulated RTF following efferent duct ligation. INSL3 was also present in the ATF (Table 2) , which is mostly derived from the seminiferous tubules (ligated fluid volume: 618 6 34 ll; unligated fluid volume: 340 6 30 ll; ATF: 277 6 58 ll; see Materials and Methods), at concentrations about 11% of those in IEF. This value is greater than the equivalent value for Cr-EDTA (2.2%-4.9% [36, 37] ), which is considered impervious to the blood-testis barrier, strongly supporting the transport of INSL3 across the blood-testis barrier into the germinal compartment. There was also a significantly elevated (vis-à-vis, PBP and TVP) concentration in the EpiF, presumed to represent mostly intraluminal fluid (Table 2) . It is to be noted that efferent duct ligation either unilaterally or bilaterally (data not shown) had no significant effect on the circulating INSL3 concentration, nor on the INSL3 concentration in the epididymal duct (Table 2) . We later confirmed ( Table 3) that there was no significant effect of efferent duct ligation (either unilateral or bilateral) on the volume of IEF that could be collected per testis.
As further confirmation of INSL3 transport across the bloodtestis barrier, the fate of human INSL3 was followed after bolus injection into the interstitial compartment of adult rat testes. We took advantage here of the high species specificity of the TRFIA assays used for the relevant peptide. Namely, the modified human INSL3 TRFIA was unable to detect rat INSL3 at any local concentration in the rodent, and thus could be securely used to measure human INSL3 in different compartments of the rat testis (Table 3) . In a preliminary time-course experiment (data not shown), human INSL3 rapidly disappeared from the IEF compartment and also from TVP. In fact, in absolute terms, ,10% of the original human INSL3 injected can be recovered in the IEF at 30 min. Hence, a time point of 30 min was chosen for the subsequent experiments. Significant levels of human INSL3 are also detectable in circulating blood after 30 min (PBP , Table 3 ), as well as at 2 and 4 h (data not shown). Human INSL3 injected into the rat testis (Table 3) was rapidly transported into testicular venous plasma (TVP), but also into the accumulated RTF following efferent duct ligation. There was no significant difference in the concentration of human INSL3 measured in IEF from intact, unligated testes
and 32 h (hatched bars) by MA-10 mouse tumour Leydig cells at various concentrations and combinations of reagent. Inset displays the results of three independent qRT-PCR measurements of the specific Insl3 mRNA in the same MA-10 cells following stimulation with 30 lM MBP, 15 nM T, or both together, and incubated for 32 h, normalized against Rps27a mRNA. C1 to C3 are appropriate controls using the corresponding vehicle for T and MBP: C1, 0.001% ethanol; C2, 0.05% DMSO; C3, 0.001% ethanol plus 0.05% DMSO, final concentrations. All results are mean 6 SEM of three independent experiments, each performed in triplicate. 484 compared with efferent duct ligated testes, again confirming the fact that efferent duct ligation has no effect on IEF dynamics. It should be noted that measurement of INSL3 content in RTF, which is the most reliable estimate of transfer to the seminiferous tubule compartment, is only feasible after efferent duct ligation; RTF cannot be obtained in appreciable quantities from the unligated testis.
DISCUSSION
INSL3 is a major Leydig cell product in every eutherian mammal so far investigated. In humans and now rodents, it has been shown also to be a major secreted hormone. Studies in humans show that, unlike testicular steroids, which are acutely governed by the components of the HPG axis, INSL3 appears to be constitutively expressed, and thus representative of the quality (functionality and number) of the Leydig cells present in the testes [16, 18, 19] . Nevertheless, as Leydig cells alter their differentiation state (e.g., in aging [44] , seasonal breeders [43, 46, 47] , mouse mutants [2] , Leydig cell tumors [48] , androgen-treated men [16] , or in those subject to a male hormonal contraceptive regimen [8 and Anand-Ivell and Ivell, unpublished results]), INSL3 expression is also correspondingly altered. It can be argued that INSL3 offers a more accurate parameter to determine true hypogonadism than those that are influenced by factors perturbing the HPG axis. This acute independence from the HPG axis is best illustrated by a study of men who have undergone unilateral orchidectomy for testicular cancer [16] . Testosterone levels in these men are not significantly different from those in normal intact men due to a compensatory upregulation of LH expression by the HPG axis. In contrast, not only are INSL3 serum concentrations significantly reduced in men with one testis, but there is a highly significant inverse correlation to LH levels, which would not be the case if INSL3 was being acutely controlled by the HPG axis [16] . Given the potential that an independent measure of Leydig cell functionality would have in assessing and treating hypogonadism, for example, in the aging male, it is important to have good model systems in which to explore the appropriate physiology. This study was carried out to extend our understanding of INSL3 physiology in the rodent from the mRNA level to that of the expressed phenotype.
We have developed a sensitive and robust immunoassay using a TRFIA platform, which is able to detect INSL3 in both rats and mice without extraction or concentration. Employing this assay, we have mapped the development of INSL3 expression (secretion) in the postnatal SD rat. Apart from reflecting the pubertal increase in Leydig cell functionality, the serum INSL3 profile indicates that there is an ''overshoot'' in Leydig cell functioning on the attainment of adulthood at 40 days (4-10 ng/ml INSL3). This is not evident for testosterone production (data not shown), which, in agreement with numerous other studies, appears to rise consistently from about Day 25 to attain steady adult levels at around Day 50-60 (e.g., [49] [50] [51] ). In addition to showing high diurnal variability [52] , testosterone is presumably regulated by the acute feedback mechanisms of the HPG axis, which act to maintain a relatively constant circulating androgen concentration. Only after the completion of several full spermatogenic cycles at ;3 mo do we see a stabilized, lower adult norm level for INSL3 of ;3 ng/ml in this strain. As expected based on earlier mRNA and immunohistochemical studies [44] , circulating INSL3 is considerably reduced in aging male rats, similar to what is observed in men [16] . Our results differ somewhat from those reported previously for Holtzman rats [17] , which showed average INSL3 concentrations at Days 40-50 of about 0.6 ng/ ml. These were measured using a heterologous assay with antimouse INSL3 antibodies and human INSL3 as tracer, which might have underestimated the rat INSL3, and also indicated high variance for the older age groups. Our own data ( Table 1 ) also suggest that there may be a marked strain-specific component to the expression of rodent INSL3.
Postpubertal female rats all have circulating INSL3 levels just above the assay detection limit ( Table 1 ). The source of this INSL3 is presumably the growing follicles of the ovary, which are recognized in humans and rodents as being able to generate INSL3 [2, 18] .
Treatment of rats with a single bolus injection of EDS kills all mature Leydig cells [30] . In the absence of any further treatment, the HPG axis is consequently upregulated through the loss of inhibitory androgen, with an increased LH output driving the differentiation of a new population of Leydig cells from resident peritubular stem cells in the testes [30] . We can follow the differentiation of the new Leydig cells via measurement of INSL3 in circulating blood, and show that, by Day 27, an INSL3 concentration can be determined, equivalent to that observed at about the same time postnatally in untreated rats. This experiment also confirms that the Leydig cells are the only significant source of circulating INSL3.
All our studies suggest that INSL3 secretion from cultured Leydig cells is also constitutive. We have failed to find any effector able to influence Insl3 gene expression at the mRNA level [2, 3] , and now at the level of peptide secretion, in spite of addressing several key second messenger systems. This is interesting, because of a recent report [44] in which it was suggested that high concentrations of androgens, and also phthalates, could act on Leydig cells to modulate Insl3 gene transcription. We have repeated this study, and fail to see a significant effect at the mRNA level or at the level of the secreted peptide. We do not understand this discrepancy. Together with our earlier results, we strongly support the view that, at the physiological level of the secreted hormone, and also at the level of mRNA expression, INSL3 is unregulated and constitutive, and reflects the functional capacity and/or number of Leydig cells.
The role of INSL3 produced by the adult testis is unclear. Although mice that have either the Insl3 gene or that for its receptor, Rxfp2, deleted appear to have no major defects, at 
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least as young adults that have had their cryptorchid testes scrotally repositioned at birth [4] , there is support for both a systemic as well as a testicular role. There is good evidence that INSL3 might be involved in bone function, with knockout mice having significantly reduced bone density [53] . INSL3 may also affect thyroid and prostate cells [54, 55] . Regarding a testicular role, besides on Leydig cells themselves, RXFP2 receptors are also present on male germ cells and in the epididymis [7, 12, 13] . A preliminary report [56] suggests that an RXFP2 antagonist can induce a loss of testicular weight, presumably caused by loss of germ cells. Finally, a recent study has shown that, of men subjected to a steroidal contraceptive regimen, those who responded poorly with high residual sperm counts had significantly higher circulating INSL3 [8] . Together with related findings from the ovary [57, 58] , these results imply that INSL3 probably functions in the gonads as a survival or antiapoptotic factor interacting directly with receptors on germ cells. For this to occur, INSL3 peptide, which is made by the Leydig cells, needs to be able to reach those germ cell or epididymal receptors within the seminiferous compartment. This is problematic because of the blood-testis barrier, comprising tight junctions linking Sertoli cells in the basal region of seminiferous tubules [24] [25] [26] [27] , and which prevents the passive transport of most proteins and peptides from the interstitial compartment to the tubular lumen, unless there are specific transport mechanisms via the basal surface of the Sertoli cells [24] [25] [26] [27] . The present study indicates appreciable concentrations of INSL3 associated with the seminiferous tubules, and especially that it appears in rete testes fluid following efferent duct ligation. Although efferent duct ligation can cause a breakdown of the Sertoli cell tight junctions responsible for the blood-testis barrier, this only occurs after at least 24 h of ligation [37] . There are also significant concentrations of INSL3 in fluid collected from the epididymis. Furthermore, bolus injection of human INSL3 into the interstitial compartment gives rise, within 30 min, to significant amounts of this exogenous peptide in the seminiferous tubules and rete testis, some of which is still detectable in rete testis fluid collected 20 h after injection (data not shown). Moreover, the results indicate that fluid collected from the epididymis also contains levels of INSL3 that are considerably higher than those in circulating blood, and presumably able to access the receptors identified on epididymal epithelial cells. This INSL3 has probably reached the epididymis from the seminiferous compartment via the male excurrent ducts. Together, these results indicate that there are mechanisms within the testis that ensure that sufficient INSL3 is transported into the seminiferous compartment, where it interacts with specific RXFP2 receptors and those in the epididymis, thus providing the essential endocrine and morphological prerequisites for a direct antiapoptotic role, vis-à-vis germ cells and for functions on other cells of the male genital tract.
